Rubius Therapeutics, Inc.
RUBYDelisted Mar 28, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001709401
Rubius Therapeutics, Inc. was delisted on Mar 28, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 42 institutions reported holding it in 13F filings for Q4 2022, worth $11.2M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Rubius Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
RUBY is no longer listed, so this page shows Q4 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 42
- −19 vs. Q3 2022
- Shares held
- 65.4M
- −3.34M (−4.9%) vs. Q3 2022
- Total value
- $11.2M
- −$18.5M (−62.3%) vs. Q3 2022
- New holders
- 5
- 10 more added
- Sold out
- 24
- 15 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RUBY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 7 | $61.3K |
| Q4 2022 | 42 | $11.2M |
| Q3 2022 | 62 | $29.7M |
| Q2 2022 | 73 | $66.6M |
| Q1 2022 | 117 | $493.9M |
| Q4 2021 | 108 | $863.6M |
| Q3 2021 | 105 | $1.55B |
| Q2 2021 | 108 | $2.09B |
| Q1 2021 | 105 | $2.23B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Rubius Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% | −16,523−99.8% | Reduced |
| JPMorgan Chase & Co | 2,196 | $0 | 0.00% | −3,561−61.9% | Reduced |
| Royal Bank of Canada | 3 | $0 | 0.00% | −456−99.3% | Reduced |
| Kelly Financial Services LLC | 100 | $18 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 200 | $35 | 0.00% | +200 | New |
| Wells Fargo & Company | 314 | $55 | 0.00% | +8+2.6% | Added |
| Advisor Group Holdings, Inc. | 325 | $57 | 0.00% | +325 | New |
| Mascoma Wealth Management LLC | 1,000 | $175 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,342 | $231 | 0.00% | +56+4.4% | Added |
| New England Capital Financial Advisors LLC | 1,107 | $251 | 0.00% | +1,107 | New |
| BNP Paribas Arbitrage, SA | 6,108 | $1.07K | 0.00% | +4,294+236.7% | Added |
| Group One Trading, L.P. | 9,920 | $1.71K | 0.00% | −10.0% | Reduced |
| Edge Wealth Management LLC | 10,000 | $1.75K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 17,511 | $3.06K | 0.00% | −27,010−60.7% | Reduced |
| Two Sigma Investments, LP | 19,200 | $3.36K | 0.00% | +19,200 | New |
| Bank of America Corp | 19,286 | $3.38K | 0.00% | +16,079+501.4% | Added |
| Bank of New York Mellon Corp | 20,990 | $3.67K | 0.00% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 22,226 | $4.00K | 0.00% | 00.0% | Unchanged |
| Clarius Group, LLC | 21,393 | $4.00K | 0.00% | −1,281−5.6% | Reduced |
| Bridgeway Capital Management, LLC | 25,200 | $4.34K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 39,307 | $6.88K | 0.00% | −16,990−30.2% | Reduced |
| Ergoteles LLC | 57,747 | $9.94K | 0.00% | +57,747 | New |
| Morgan Stanley | 62,273 | $10.9K | 0.00% | −14,057−18.4% | Reduced |
| Virtu Financial LLC | 68,825 | $12.0K | 0.00% | +41,338+150.4% | Added |
| Northern Trust Corp | 71,366 | $12.5K | 0.00% | −127−0.2% | Reduced |
| UBS Group AG | 72,662 | $13.1K | 0.00% | +60,676+506.2% | Added |
| New York Life Investment Management LLC | 102,251 | $17.6K | 0.00% | +10,908+11.9% | Added |
| Citadel Advisors LLC | 132,322 | $22.8K | 0.00% | −9,458−6.7% | Reduced |
| State Street Corp | 147,789 | $25.4K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 150,000 | $26.3K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 169,571 | $29.0K | 0.00% | −55,193−24.6% | Reduced |
| Renaissance Technologies LLC | 200,190 | $35.0K | 0.00% | +71,600+55.7% | Added |
| Geode Capital Management, LLC | 412,218 | $70.0K | 0.00% | −23,428−5.4% | Reduced |
| State of Michigan Retirement System | 640,000 | $110.1K | 0.00% | 00.0% | Unchanged |
| HarbourVest Partners LLC | 986,878 | $172.7K | 0.06% | 00.0% | Unchanged |
| BlackRock Inc. | 1,197,501 | $209.6K | 0.00% | −390,426−24.6% | Reduced |
| Acadian Asset Management LLC | 1,277,196 | $222.0K | 0.00% | +614,522+92.7% | Added |
| Vanguard Group Inc | 1,676,669 | $293.4K | 0.00% | −28,619−1.7% | Reduced |
| Artal Group S.A. | 2,042,666 | $357.0K | 0.02% | 00.0% | Unchanged |
| Baillie Gifford & Co | 4,869,126 | $838.0K | 0.00% | +15,353+0.3% | Added |
| FMR LLC | 12,376,153 | $2.13M | 0.00% | −1,081,346−8.0% | Reduced |
| Flagship Pioneering Inc. | 38,506,526 | $6.55M | 0.21% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −544,238−100.0% | Sold out |
| Abbot Financial Management, Inc. | 0 | $0 | 0.00% | −452,345−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −425,497−100.0% | Sold out |
| ARCH Venture Management, LLC | 0 | $0 | 0.00% | −349,908−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −256,194−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −111,323−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −96,985−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −70,400−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −38,225−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −31,849−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −31,143−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −29,400−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,784−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −21,844−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −19,975−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −20,425−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −18,270−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −15,100−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −10,417−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −10,753−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −4,400−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,735−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −307−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −846−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |